According to Gram Research analysis, a 2026 study shows that fat buildup inside the pancreas accelerates pancreatic cancer growth and spread through a protein called FABP5. When researchers blocked FABP5 in cancer cells, tumor growth slowed significantly without serious side effects, suggesting this protein could become a new treatment target for pancreatic cancer.
According to Gram Research analysis, a new study shows that fat buildup inside the pancreas may help pancreatic cancer grow faster and spread to other parts of the body. Scientists used mice fed a high-fat diet to understand how this happens. They discovered that a protein called FABP5 plays a key role in making cancer cells multiply and move around. When researchers blocked this protein in lab tests, tumor growth slowed down. These findings suggest that targeting FABP5 could become a new way to treat pancreatic cancer, though more research in humans is needed before doctors can use this approach.
Key Statistics
A 2026 research article published in Scientific Reports found that mice with high intrapancreatic fat developed pancreatic cancer tumors that grew rapidly and spread to the liver at significantly higher rates than mice without pancreatic fat buildup.
In laboratory studies, blocking the FABP5 protein with the drug BMS-309,403 suppressed pancreatic cancer tumor growth without causing serious side effects, according to a 2026 Scientific Reports study.
A 2026 study in Scientific Reports identified FABP5 as a key protein that promotes pancreatic cancer cell proliferation and migration by upregulating RAC1, a cellular protein associated with cancer cell movement.
The Quick Take
- What they studied: Whether fat stored inside the pancreas makes pancreatic cancer grow faster and spreads to other organs, and what causes this to happen
- Who participated: Laboratory mice fed a high-fat diet to develop pancreatic fat buildup, plus cancer cells grown in dishes to test protein blocking
- Key finding: Mice with high pancreatic fat developed pancreatic cancer that grew rapidly and spread to the liver. Blocking a protein called FABP5 slowed tumor growth without major side effects
- What it means for you: This research is early-stage and only tested in mice and lab cells. If human studies confirm these findings, FABP5 blocking could become a new pancreatic cancer treatment, but this is likely years away
The Research Details
Scientists created mice with high fat buildup in their pancreas by feeding them a special high-fat diet for 30 weeks. They then studied how pancreatic tissue changed by looking at which genes and proteins became more active. Next, they implanted human pancreatic cancer cells into these mice to see if the fat buildup made cancer grow faster. Finally, they tested a drug that blocks FABP5 protein in cancer cells grown in laboratory dishes to see if it stopped cancer cell growth and movement.
This multi-step approach allowed researchers to understand the problem at different levels: in whole animals, in tumor tissue, and in individual cancer cells. Each step built on the previous one to create a complete picture of how pancreatic fat and cancer interact.
This research design is important because it bridges the gap between basic science and real-world disease. By testing in mice first, researchers could see if their theory works in a living system before considering human trials. Testing in lab dishes allowed them to understand exactly which protein causes the problem and whether blocking it is safe
The study was published in Scientific Reports, a respected peer-reviewed journal. The researchers used multiple approaches to confirm their findings, which strengthens confidence in the results. However, this is animal and laboratory research, not human studies, so results may not directly apply to people. The study also didn’t specify exact sample sizes for all experiments
What the Results Show
Mice fed the high-fat diet for 30 weeks developed significantly more fat inside their pancreas compared to control mice eating normal food. When cancer cells were implanted into these high-fat mice, tumors grew much faster than in mice without pancreatic fat buildup. The high-fat mice also developed liver cancer spread (metastasis) and cancer cells in their abdomens at higher rates.
When researchers examined the pancreatic tissue, they found that a protein called FABP5 was much more active in mice with high pancreatic fat. This protein appears to activate several cellular pathways that help cancer cells multiply and spread. In laboratory dishes, cancer cells with high FABP5 levels grew faster and moved more easily than cells with normal FABP5 levels.
Most importantly, when scientists used a drug called BMS-309,403 to block FABP5 in cancer cells, tumor growth slowed significantly without causing serious side effects. This suggests that FABP5 blocking could be a potential treatment approach.
The study found that high pancreatic fat also increased activity of several cellular signaling pathways known to promote cancer growth, including JAK/STAT, PI3K/AKT/mTOR, and Ras/Raf/MEK/ERK pathways. A protein called RAC1, which helps cancer cells move and invade other tissues, was also more active when FABP5 was high. These findings suggest that FABP5 works by activating multiple cancer-promoting mechanisms simultaneously
Previous research had shown that pancreatic fat buildup increases pancreatic cancer risk, but scientists didn’t understand why. This study provides the first detailed explanation of the mechanism, identifying FABP5 as a key player. The findings align with broader research showing that obesity and fat buildup in organs increase cancer risk, but this is the first study to pinpoint FABP5’s specific role in pancreatic cancer
This research was conducted entirely in mice and laboratory cells, not in humans. Mice don’t always respond to treatments the same way humans do. The study didn’t test the FABP5-blocking drug in living mice with tumors, only in cancer cells in dishes. The exact sample sizes for some experiments weren’t clearly reported. Additionally, the study doesn’t address whether people can reduce pancreatic fat through diet or lifestyle changes, or whether such changes would slow cancer growth
The Bottom Line
This research is too early-stage to recommend specific actions for people. If you have pancreatic cancer or family history of it, discuss these findings with your oncologist, but FABP5 blocking is not yet available as a treatment. Maintaining a healthy weight and avoiding high-fat diets remains important general cancer prevention advice based on broader research evidence (moderate confidence)
People with pancreatic cancer or strong family history of pancreatic cancer should be aware of this research direction. Oncologists and pancreatic cancer researchers should follow this work closely. The general public should understand this as promising early research, not as a current treatment option. People concerned about pancreatic cancer risk should focus on proven prevention strategies like maintaining healthy weight and avoiding smoking
If these findings hold up in human studies, it would likely take 5-10 years before FABP5-blocking drugs could become available for pancreatic cancer patients. Clinical trials in humans would need to happen first to confirm safety and effectiveness
Frequently Asked Questions
Does pancreatic fat cause pancreatic cancer?
High pancreatic fat appears to accelerate pancreatic cancer growth and spread, according to 2026 research. However, this doesn’t mean fat alone causes cancer. The study shows fat creates conditions that help existing cancer cells grow faster
Can blocking FABP5 treat pancreatic cancer in humans?
Not yet. A 2026 study showed FABP5 blocking slowed tumor growth in mice and lab cells, but human clinical trials haven’t been conducted. This is early-stage research that may lead to future treatments
What is FABP5 and why does it matter?
FABP5 is a protein that becomes more active when pancreatic fat is high. It helps cancer cells multiply and spread by activating cellular pathways. Blocking it slowed cancer growth in laboratory studies
Can I reduce pancreatic fat through diet?
Maintaining a healthy weight through balanced diet and exercise likely helps reduce pancreatic fat, though this study didn’t directly test this. General cancer prevention advice recommends avoiding high-fat diets and maintaining healthy weight
Who should be concerned about pancreatic fat and cancer?
People with obesity, type 2 diabetes, or family history of pancreatic cancer may have higher pancreatic fat. Anyone concerned should discuss pancreatic cancer risk factors with their doctor and focus on proven prevention strategies
Want to Apply This Research?
- Track daily fat intake in grams and weekly weight. Users can log meals and monitor whether reducing dietary fat correlates with weight changes, building awareness of fat consumption patterns
- Set a daily fat intake goal (typically 50-70 grams for most people) and log meals to stay within target. Users can identify high-fat foods to reduce and find lower-fat alternatives they enjoy
- Weekly weigh-ins combined with monthly body composition tracking. Users can also track energy levels and digestive comfort to see if reducing fat intake improves how they feel
This article summarizes early-stage laboratory and animal research. The findings have not been tested in human patients, and FABP5-blocking drugs are not currently available as cancer treatments. This research should not be used to diagnose, treat, or prevent pancreatic cancer. Anyone with concerns about pancreatic cancer risk or diagnosis should consult with a qualified healthcare provider or oncologist. This article is for educational purposes only and does not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.